The Clorox Company reported fourth-quarter net sales of $1.95 billion, a 2% decrease year-over-year, and a diluted EPS of $1.34. For the full fiscal year 2026, net sales declined 5% to $6.72 billion, with diluted EPS falling 26% to $4.81. The company's results were significantly impacted by lapping prior-year incremental shipments related to its ERP system transition, which masked underlying performance but were offset by the recent acquisition of GOJO Industries.
Key Highlights
- Fourth-quarter net sales decreased 2% to $1.95 billion, as a 10-point contribution from the GOJO acquisition was more than offset by a 13% decline in organic sales. The organic sales drop was primarily driven by a 13.5-point headwind from lapping prior-year ERP-related shipments.
- Full-year fiscal 2026 net sales fell 5% to $6.72 billion. Organic sales for the year decreased 8%, with the ERP-related shipment comparison accounting for a 7.5 point decline.
- The company introduced its fiscal year 2027 outlook, projecting net sales growth of 13% to 14%, which includes about 9.5 points of benefit from the GOJO acquisition. Organic sales are expected to grow 3.5% to 4.5%.
- Fiscal year 2027 adjusted EPS is forecast to be between $5.70 and $6.00, representing growth of 3% to 8%, benefiting from lapping the prior-year ERP inventory drawdown.